Back
Channel Therapeutics Stock Price Chart
10 stocks to buy for the next leg of this rally
Get the full list here FREE
Sell
8
CHRO
Channel Therapeutics
Last Price:
$0.92
Seasonality Move:
-39.34%
7 Day Trial
ALL ACCESS PASS
$
7
10 Best Stocks to Own in 2025
Get your copy now FREE!-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CHRO is experiencing selling pressure, which indicates risk of future bearish movement.
Channel Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.97 | Sell |
| 20-day SMA: | 1.04 | Sell |
| 50-day SMA: | 1.26 | Sell |
| 200-day SMA: | 1.12 | Sell |
| 8-day EMA: | 0.97 | Sell |
| 20-day EMA: | 1.05 | Sell |
| 50-day EMA: | 1.22 | Sell |
| 200-day EMA: | 1.4 | Sell |
Channel Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.1 | Sell |
| Relative Strength Index (14 RSI): | 34.93 | Sell |
| Chaikin Money Flow: | -27643 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.96 - 1.22) | Sell |
| Bollinger Bands (100): | (1.06 - 1.98) | Sell |
Channel Therapeutics Technical Analysis
| May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 16 | 19 | 20 | 21 | 22 | 23 | 27 | 28 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Channel Therapeutics Stock
Is Channel Therapeutics Stock a Buy?
-
Channel Therapeutics share price is 0.93 while CHRO 8-day simple moving average is 0.97, which is a Sell signal.
-
The stock price of CHRO is 0.93 while Channel Therapeutics 20-day SMA is 1.04, which makes it a Sell.
-
Channel Therapeutics 50-day simple moving average is 1.26 while CHRO share price is 0.93, making it a Sell technically.
-
CHRO stock price is 0.93 and Channel Therapeutics 200-day simple moving average is 1.12, creating a Sell signal.
CHRO Technical Analysis vs Fundamental Analysis
Sell
8
Channel Therapeutics (CHRO)
is a Sell
Is Channel Therapeutics a Buy or a Sell?
-
Channel Therapeutics stock is rated a SellThe current Channel Therapeutics [CHRO] share price is $0.93. The Score for CHRO is 8, which is 84% below its historic median score of 50, and infers higher risk than normal.
Channel Therapeutics Stock Info
Market Cap:
5.3M
Price in USD:
0.93
Share Volume:
34.7K
Channel Therapeutics 52-Week Range
52-Week High:
3.80
52-Week Low:
0.45
Sell
8
Channel Therapeutics (CHRO)
is a Sell
Channel Therapeutics Share Price Forecast
-
What is the Channel Therapeutics stock price today?The Channel Therapeutics stock price is 0.93 USD today.
-
Will CHRO stock go up or go down?Channel Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Channel Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Channel Therapeutics is overvalued.
Is Channel Therapeutics Stock a Buy?
-
Channel Therapeutics share price is 0.93 while CHRO 8-day exponential moving average is 0.97, which is a Sell signal.
-
The stock price of CHRO is 0.93 while Channel Therapeutics 20-day EMA is 1.05, which makes it a Sell.
-
Channel Therapeutics 50-day exponential moving average is 1.22 while CHRO share price is 0.93, making it a Sell technically.
-
CHRO stock price is 0.93 and Channel Therapeutics 200-day simple moving average is 1.40, creating a Sell signal.
Fundamental Analysis of Channel Therapeutics
Is Channel Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.20 per share, and an increase next year of $0.05 per share.
Technical Analysis of Channel Therapeutics
Should I short Channel Therapeutics stock?
-
CHRO Moving Average Covergence Divergence (MACD) indicator is -0.1, suggesting Channel Therapeutics is a Sell
-
Channel Therapeutics Relative Strength Index (RSI) is 34.93, which suggest Channel Therapeutics is oversold
-
The Bollinger Bands (25) for Channel Therapeutics is (0.96 - 1.22), which suggest Channel Therapeutics is a Sell
-
The Bollinger Bands (100) for Channel Therapeutics is (1.06 - 1.98), which suggest Channel Therapeutics is a Sell
* Channel Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.